Molecular Pathology of Non–Small Cell Lung Cancer
- 1 December 2012
- journal article
- Published by Elsevier BV in Surgical Pathology Clinics
- Vol. 5 (4), 903-918
- https://doi.org/10.1016/j.path.2012.08.006
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- Multiplex Mutation Screening by Mass Spectrometry: Evaluation of 820 Cases from a Personalized Cancer Medicine RegistryThe Journal of Molecular Diagnostics, 2011
- Biomarkers of clinical benefit for anti-epidermal growth factor receptor agents in patients with non-small-cell lung cancerBritish Journal of Cancer, 2011
- Rational, biologically based treatment of EGFR-mutant non-small-cell lung cancerNature Reviews Cancer, 2010
- The biology and treatment of EML4-ALK non-small cell lung cancerEuropean Journal of Cancer, 2010
- Rapid targeted mutational analysis of human tumours: a clinical platform to guide personalized cancer medicineEMBO Molecular Medicine, 2010
- Preexistence and Clonal Selection of MET Amplification in EGFR Mutant NSCLCCancer Cell, 2010
- MET as a target for treatment of chest tumorsLung Cancer, 2009
- MET gene amplification or EGFR mutation activate MET in lung cancers untreated with EGFR tyrosine kinase inhibitorsInternational Journal of Cancer, 2009
- Somatic mutations affect key pathways in lung adenocarcinomaNature, 2008
- Salivary gland-type lung carcinomas: an EGFR immunohistochemical, molecular genetic, and mutational analysis studyLaboratory Investigation, 2008